Celgene Corporation (NASDAQ:CELG): Current price $85.74
Jefferies raised their estimates and price target for Celgene Corporation noting the company’s new 2017 guidance, which the firm stated reflects stronger than expected operating margin leverage. Jefferies keeps a Buy rating on Celgene, which was upgraded at both RBC Capital and Piper Jaffray.
Save time and make money with our LOWEST ADVERTISED PRICE EVER to help you achieve your financial goals in 2013. This is a LIMITED TIME OFFER, so get your Stock Picker Newsletter now!
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more